CTIS.eu › Cities › France › Suresnes
Suresnes
France
212 total trials
97 recruiting
2024-513173-44-00
4
2022-05-03
Adults patients having non severe HLH
2023-503572-24-00
5
2022-03-02
Chronic Obstructive Pulmonary Disease (COPD)
2024-514570-43-00
5
2022-01-24
Renal cell carcinoma
2024-513707-14-00
5
2022-01-14
Only patients with oncologic locally advanced or metastatic tumour (lu
2023-507431-37-00
5
2021-07-23
relapsing multiple sclerosis (RMS)
2023-503280-42-00
5
2021-06-01
Metastatic Clear Cell Renal Cell Carcinoma
2023-508485-15-00
5
2021-04-22
Subjects with documented STEMI, presenting with persistent ischemic ch
2023-505273-33-00
5
2021-02-15
"Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial
(NTM
2024-516407-16-00
5
2020-04-10
Patients admitted to the ICU proven or suspected infection as the main
2023-507148-35-00
5
2019-10-03
Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastroint
2024-516201-23-00
4
2019-08-26
Lung Cancer, NSCLC
2022-500785-10-00
5
2019-08-23
Metastatic Castration-Resistant Prostate Cancer
2024-514586-20-01
5
2018-05-02
Non small cell lung cancer
2024-516783-29-00
6
2018-04-16
Severe allergic and eosinophilic asthma
2024-517439-39-00
7
2018-03-19
Metastatic castration-resistant prostate cancer.
2022-501784-40-00
5
2017-05-26
Untreated Unresectable or Metastatic Urothelial Cancer
2022-502526-41-00
4
2016-03-15
Non-Muscle Invasive Bladder Cancer (NMIBC)
2024-517856-36-00
5
2015-03-09
Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce
2023-508120-35-00
6
Patient presenting to the neuroradiological emergency room with an isc
2023-509615-92-00
4
Ischemic stroke with Large Core
Showing 193–212 of 212 trials